Human peripheral blood B-Cell compartments: A crossroad in B-cell traffic

Cytometry Part B - Clinical Cytometry

Volumn 78, Issue SUPPL. 1, 2010, Pages

  Perez Andres, M ^a   Paiva, B ^a,b   Nieto, W G ^a   Caraux, A ^c   Schmitz, A ^d   Almeida, J ^a   Vogt Jr , R F ^e   Marti, G E ^f   Rawstron, A C ^g,h   Van Zelm, M C ⁱ   Van Dongen, J J M ⁱ   Johnsen, H E ^d   Klein, B ^c,j,k   Orfao, A ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c INSERM   (France)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g St James's Institute of Oncology   (United Kingdom)

^h St James's Institute of Oncology   (United Kingdom)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j MONTPELLIER UNIVERSITY HOSPITAL   (France)

^k UNIV MONTPELLIER   (France)

more..

Author keywords

B cell; Circulating; Differentiation; Peripheral blood; Subsets

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

AGE DISTRIBUTION; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTOSIS; LYMPHOID TISSUE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; REVIEW; SEASONAL VARIATION; SPAIN;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTE SUBSETS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; GERMINAL CENTER; HUMANS; IMMUNOPHENOTYPING; MIDDLE AGED; YOUNG ADULT;

EID: 77956571407     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20547     Document Type: Review

References (111)

1. Nagasawa T. Microenvironmental niches in the bone marrow required for B-cell development. Nat Rev Immunol 2006;6:107-116. (Pubitemid 43361586)
2. Allen CD, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity 2007;27:190-202.
3. McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol 2005;23:487-513.
4. Acosta-Rodríguez EV, Merino MC, Montes CL, Motrán CC, Gruppi A. Cytokines and chemokines shaping the B-cell compartment. Cytokine Growth Factor Rev 2007;18:73-83. (Pubitemid 46401431)
5. van Lochem EG, van der Velden VH, Wind HK, te Marvelde JG, Westerdaal NA, van Dongen JJ. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age-related changes and disease-induced shifts. Cytometry B Clin Cytom 2004;60B:1-13.
6. Tangye SG, Tarlinton DM. Memory B cells: Effectors of long-lived immune responses. Eur J Immunol 2009;39:2065-2075.
7. Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dörner T, Hiepe F. Competence and competition: The challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006;6:741-750.
8. LeBien TW, Tedder TF. B lymphocytes: How they develop and function. Blood 2008;112:1570-1580.
9. Klein U, Rajewsky K, Küppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998;188:1679-1689.
10. Tangye SG, Liu YJ, Aversa G, Phillips JH, de Vries JE. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med 1998;188:1691-1703.
11. Xiao Y, Hendriks J, Langerak P, Jacobs H, Borst J. CD27 is acquired by primed B cells at the centroblast stage and promotes germinal center formation. J Immunol 2004;172:7432-7441.
12. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005;105:4390-4398.
13. Cuss AK, Avery DT, Cannons JL, Yu LJ, Nichols KE, Shaw PJ, Tangye SG. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol 2006;176:1506-1516.
14. Le e J, Kuchen S, Fischer R, Chang S, Lipsky PE. Identification and characterization of ahuman CD5+ pre-naive B cell population. J Immunol 2009;182:4116-4126.
15. + plasma cells. Haematologica 2010;95:1015-1020.
16. Marie-Cardine A, Divay F, Dutot I, Green A, Perdrix A, Boyer O, Contentin N, Tilly H, Tron F, Vannier JP, Jacquot S. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol 2008;127:14-25.
17. Waddick KG, Uckun FM. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation. Exp Hematol 1993;21:791-798.
18. Espeli M, Rossi B, Mancini SJ, Roche P, Gauthier L, Schiff C. Initiation of pre-B cell receptor signaling: Common and distinctive features in human and mouse. Semin Immunol 2006;18:56-66.
19. Carsetti R. The development of B cells in the bone marrow is controlled by the balance between cell-autonomous mechanisms and signals from the microenvironment. J Exp Med 2000;191:5-8.
20. Zhu J, Garrett R, Jung Y, Zhang Y, Kim N, Wang J, Joe GJ, Hexner E, Choi Y, Taichman RS, Emerson SG. Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 2007;109:3706-3712. (Pubitemid 46641719)
21. Monteiro JP, Benjamin A, Costa ES, Barcinski MA, Bonomo A. Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells. Blood 2005;105:1484-1491. (Pubitemid 40223664)
22. Sapoznikov A, Pewzner-Jung Y, Kalchenko V, Krauthgamer R, Shachar I, Jung S. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat Immunol 2008;9:388-395. (Pubitemid 351405108)
23. Eaton-Bassiri A, Dillon SB, Cunningham M, Rycyzyn MA, Mills J, Sarisky RT, Mbow ML. Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells. Infect Immunol 2004;72:7202-7211. (Pubitemid 39552391)
24. van Zelm MC, van der Burg M, de Ridder D, Barendregt BH, de Haas EF, Reinders MJ, Lankester AC, Révész T, Staal FJ, van Dongen JJ. Ig gene rearrangement steps are initiated in early human precursor B cell subsets and correlate with specific transcription factor expression. J Immunol 2005;175:5912-5922. (Pubitemid 41508076)
25. Egawa T, Kawabata K, Kawamoto H, Amada K, Okamoto R, Fujii N, Kishimoto T, Katsura Y, Nagasawa T. The earliest stages of B cell development require a chemokine stromal cell-derived factor/pre-B cell growth-stimulating factor. Immunity 2001;15:323-334. (Pubitemid 32816880)
26. Stoddart A, Ray RJ, Paige CJ. Analysis of murine CD22 during B cell development: CD22 is expressed on B cell progenitors prior to IgM. Int Immunol 1997;9:1571-1579. (Pubitemid 27434690)
27. Tokoyoda K, Egawa T, Sugiyama T, Choi BI, Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004;20:707-718. (Pubitemid 38757441)
28. Pelayo R, Welner RS, Nagai Y, Kincade PW. Life before the pre-B cell receptor checkpoint: Specification and commitment of primitive lymphoid progenitors in adult bone marrow. Semin Immunol 2006;18:2-11.
29. Hillion S, Rochas C, Youinou P, Jamin C. Signaling pathways regulating RAG expression in B lymphocytes. Autoimmun Rev 2009;8:599-604.
30. Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology, 6th ed. St. Louis, MO: WB Saunders Company; 2007.
31. Cambier JC. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol 1995;155:3281-3285.
32. Löffert D, Ehlich A, Müller W, Rajewsky K. Surrogate light chain expression is required to establish immunoglobulin heavy chain allelic exclusion during early B cell development. Immunity 1996;4:133-144.
33. Espeli M, Mancini SJ, Breton C, Poirier F, Schiff C. Impaired B-cell development at the pre-BII-cell stage in galectin-1-deficient mice due to inefficient pre-BII/stromal cell interactions. Blood 2009;113:5878-5886.
34. Hess J, Werner A, Wirth T, Melchers F, Jäck HM, Winkler TH. Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. Proc Natl Acad Sci USA 2001;98:1745-1750.
35. Radic MZ, Zouali M. Receptor editing, immune diversification, and self-tolerance. Immunity 1996;5:505-511.
36. Chen C, Prak EL, Weigert M. Editing disease-associated autoantibodies. Immunity 1997;6:97-105.
37. Tokoyoda K, Zehentmeier S, Chang HD, Radbruch A. Organization and maintenance of immunological memory by stroma niches. Eur J Immunol 2009;39:2095-2099.
38. Thomas MD, Srivastava B, Allman D. Regulation of peripheral B cell maturation. Cell Immunol 2006;239:92-102.
39. Wasserstrom H, Bussel J, Lim LC, Cunningham-Rundles C. Memory B cells and pneumococcal antibody after splenectomy. J Immunol 2008;181:3684-3689.
40. Traub A, Giebink GS, Smith C, Kuni CC, Brekke ML, Edlund D, Perry JF. Splenic reticuloendothelial function after splenectomy, spleen repair, and spleen autotransplantation. N Engl J Med 1987;317:1559-1564.
41. Dung M, Landmann RMA, Harder F. Lymphocyte subsets in human peripheral blood after splenectomy and autotransplantation of splenic tissue. J Lab Clin Med 1984;104:110-115.
42. -Marti GE, Ryan ET, Papadopoulos NM, Filling-Katz M, Barton N, Fleisher TA, Rick M, Gralnick HR. Polyclonal B cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher's disease. Am J Hematol 1988;29:189-194.
43. Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N, Cyster JG. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 2004;5:943-952.
44. Klein U, Tu Y, Stolovitzky GA, Keller JL, Haddad J Jr, Miljkovic V, Cattoretti G, Califano A, Dalla-Favera R. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci USA 2003;100:2639-2644.
45. Hennino A, Bérard M, Krammer PH, Defrance T. FLICE-inhibitory protein is a key regulator of germinal center B cell apoptosis. J Exp Med 2001;193:447-458.
46. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol 2005;5:230-242.
47. Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME, Plebani A, Kumararatne DS, Bonnet D, Tournilhac O, Tchernia G, Steiniger B, Staudt LM, Casanova JL, Reynaud CA, Weill JC. Human blood IgM "memory". B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004;104:3647-3654.
48. Weller S, Faili A, Garcia C, Braun MC, Le Deist FF, de Saint Basile GG, Hermine O, Fischer A, Reynaud CA, Weill JC. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci USA 2001;98:1166-1170.
49. van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJ. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med 2007;204:645-655.
50. Ma CS, Pittaluga S, Avery DT, Hare NJ, Maric I, Klion AD, Nichols KE, Tangye SG. Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. J Clin Invest 2006;116:322-333.
51. Good KL, Avery DT, Tangye SG. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 2009;182:890-901.
52. Seifert M, Küppers R. Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. J Exp Med 2009;206:2659-2669.
53. Fecteau JF, Côté G, Néron S. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 2006;177:3728-3736.
54. Erazo A, Kutchukhidze N, Leung M, Christ AP, Urban JF Jr, Curotto de Lafaille MA, Lafaille JJ. Unique maturation program of the IgE response in vivo. Immunity 2007;26:191-203.
55. Achatz-Straussberger G, Zaborsky N, Königsberger S, Feichtner S, Lenz S, Peckl-Schmid D, Lamers M, Achatz G. Limited humoral immunoglobulin E memory influences serum immunoglobulin E levels in blood. Clin Exp Allergy 2009;39:1307-1313.
56. Maurer D, Fischer GF, Fae I, Majdic O, Stuhlmeier K, Von Jeney N, Holter W, Knapp W. IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset. J Immunol 1992;148:3700-3705.
57. Tangye SG, Nichols KE, Hare NJ, van de Weerdt BC. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation. J Immunol 2003;171:2485-2495.
58. Bernasconi NL, Onai N, Lanzavecchia A. A role for Toll-like receptors in acquired immunity: Up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003;101:4500-4504.
59. Fecteau JF, Néron S. CD40 stimulation of human peripheral B lymphocytes: Distinct response from naive and memory cells. J Immunol 2003;171:4621-4629.
60. Jourdan M, Caraux A, De Vos J, Fiol G, Larroque M, Cognot C, Bret C, Duperray C, Hose D, Klein B. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. Blood 2009;114:5173-5181.
61. Mei HE, Yoshida T, Sime W, Hiepe F, Thiele K, Manz RA, Radbruch A, Dörner T. Blood-borne human plasma cells in steady state are derived from mucosal immune responses. Blood 2009;113:2461-2469.
62. Odendahl M, Mei H, Hoyer BF, Jacobi AM, Hansen A, Muehlinghaus G, Berek C, Hiepe F, Manz R, Radbruch A, Dörner T. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 2005;105:1614-1621.
63. Brandtzaeg P, Johansen FE. Mucosal B cells: Phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 2005;206:32-63.
64. Chen K, Xu W, Wilson M, He B, Miller NW, Bengtén E, Edholm ES, Santini PA, Rath P, Chiu A, Cattalini M, Litzman J, B Bussel J, Huang B, Meini A, Riesbeck K, Cunningham-Rundles C, Plebani A, Cerutti A. Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nat Immunol 2009;10:889-898.
65. Aurran-Schleinitz T, Aurran-Schleinitz T, Telford W, Perfetto S, Caporaso N, Wilson W, Stetler-Stevenson MA, Zenger VE, Abbasi F, Marti GE. Identification of a new monoclonal B-cell subset in unaffected first-degree relatives in familial chronic lymphocytic leukemia. Leukemia 2005;19:2339-2341.
66. Mix E, Goertsches R, Zett UK. Immunoglobulins-basic considerations. J Neurol 2006;253(Suppl 5):V9-V17.
67. Sundström P, Lundin SB, Nilsson LA, Quiding-Järbrink M. Human IgA-secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC). Eur J Immunol 2008;38:3327-3338.
68. He B, Xu W, Santini PA, Polydorides AD, Chiu A, Estrella J, Shan M, Chadburn A, Villanacci V, Plebani A, Knowles DM, Rescigno M, Cerutti A. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 2007;26:812-826.
69. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002;298:2199-2202.
70. Rojas OL, Narváez CF, Greenberg HB, Angel J, Franco MA. Characterization of rotavirus specific B cells and their relation with serological memory. Virology 2008;380:234-242.
71. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007;357:1903-1915.
72. Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum 2004;50:3580-3590.
73. Vital EM, Dass S, Rawstron AC, Buch MH, Goëb V, Henshaw K, Ponchel F, Emery P. Management of non-response to rituximab in rheumatoid arthritis: Predictors and outcome of retreatment. Arthritis Rheum 2010;62:1273-1279.
74. Suryani S, Fulcher DA, Santner-Nanan B, Nanan R, Wong M, Shaw PJ, Gibson J, Williams A, Tangye SG. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood 2010;21:115:519-529.
75. Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C. CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010;14:129-140.
76. Engelke M, Engels N, Dittmann K, Stork B, Wienands J. Ca(2+) signaling in antigen receptor-activated B lymphocytes. Immunol Rev 2007;218:235-246.
77. Rickert RC. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr Opin Immunol 2005;17:237-243.
78. Batista FD, Arana E, Barral P, Carrasco YR, Depoil D, Eckl-Dorna J, Fleire S, Howe K, Vehlow A, Weber M, Treanor B. The role of integrins and coreceptors in refining thresholds for B-cell responses. Immunol Rev 2007;218:197-213.
79. Sen G, Bikah G, Venkataraman C, Bondada S. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur J Immunol 1999;29:3319-3328.
80. Dalloul A. CD5: A safeguard against autoimmunity and a shield for cancer cells. Autoimmun Rev 2009;8:349-353.
81. Pritchard NR, Smith KG. B cell inhibitory receptors and autoimmunity. Immunology 2003;108:263-273.
82. Li H, Ayer LM, Lytton J, Deans JP. Store-operated cation entry mediated by CD20 in membrane rafts. J Biol Chem 2003;278:42427-42434.
83. Van Zelm MC, Smet J, Adams B, Mascart F, Schandené L, Janssen F, Ferster A, Kuo CC, Levy S, Van Dongen JJ, Van der Burg M. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010;120:1265-1274.
84. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O'Shea MA, Roby G, Kottilil S, Arthos J, Proschan MA, Chun TW, Fauci AS. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 2008;205:1797-1805.
85. Rakhmanov M, Keller B, Gutenberger S, Foerster C, Hoenig M, Driessen G, van der Burg M, van Dongen JJ, Wiech E, Visentini M, Quinti I, Prasse A, Voelxen N, Salzer U, Goldacker S, Fisch P, Eibel H, Schwarz K, Peter HH, Warnatz K. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci USA 2009;106:13451-13456.
86. Lougaris V, Badolato R, Ferrari S, Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: Clinical, molecular, and immunological features. Immunol Rev 2005;203:48-66.
87. Johnson-Léger C, Christenson JR, Holman M, Klaus GG. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells. J Immunol 1998;161:4618-4626.
88. Amu S, Tarkowski A, Dörner T, Bokarewa M, Brisslert M. The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool. Scand J Immunol 2007;66:77-86.
89. Chung JB, Sater RA, Fields ML, Erikson J, Monroe JG. CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals. Int Immunol 2002;14:157-166.
90. McWhirter JR, Kretz-Rommel A, Saven A, Maruyama T, Potter KN, Mockridge CI, Ravey EP, Qin F, Bowdish KS. Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation. Proc Natl Acad Sci USA 2006;103:1041-1046.
91. Bishop GA, Hostager BS. B lymphocyte activation by contact-mediated interactions with T lymphocytes. Curr Opin Immunol 2001;13:278-285.
92. Krammer PH. CD95's deadly mission in the immune system. Nature 2000;407:789-795.
93. Kunkel EJ, Butcher EC. Plasma-cell homing. Nat Rev Immunol 2003;3:822-829.
94. Henneken M, Dörner T, Burmester GR, Berek C. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 2005;7:R1001-R1013.
95. Peng SL. Signaling in B cells via Toll-like receptors. Curr Opin Immunol 2005;17:230-236.
96. Oefner C, Roques BP, Fournie-Zaluski M-C, Dale GE. Structural analysis of neprilysin with various specific and potent inhibitors. Acta Crystallogr D Biol Crystallogr 2004;60:392-396.
97. Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E, Vaisitti T, Aydin S. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev 2008;88:841-886.
98. Liu Y, Chen GY, Zheng P. CD24-Siglec G/10 discriminates danger-from pathogen-associated molecular patterns. Trends Immunol 2009;30:557-561.
99. Yunta M, Lazo PA. Apoptosis protection and survival signal by the CD53 tetraspanin antigen. Oncogene 2003;22:1219-1224.
100. Barclay NA, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA. The Leucocyte Antigen FactsBook. London: Elsevier Inc.; 1997.
101. Perez-Andres M, Santiago M, Almeida J, Mateo G, Porwit-MacDonald A, Bjorklund E, Valet G, Kraan J, Gratama JW, D'Hatcourt JL, Merle-Beral H, Lima M, Montalban MA, San Miguel JF, Orfao A. Immunophenotypic approach to the identification and characterization of clonal plasma cells from patients with monoclonal gammopathies. J Biol Regul Homeost Agents 2004;18:392-398.
102. Rawstron AC, Orfao A, Beksac M, Bezdickova L, Brooimans RA, Bumbea H, Dalva K, Fuhler G, Gratama J, Hose D, Kovarova L, Lioznov M, Mateo G, Morilla R, Mylin AK, Omedé P, Pellat-Deceunynck C, Perez Andres M, Petrucci M, Ruggeri M, Rymkiewicz G, Schmitz A, Schreder M, Seynaeve C, Spacek M, de Tute RM, Van Valckenborgh E, Weston-Bell N, Owen RG, San Miguel JF, Sonneveld P, Johnsen HE; European Myeloma Network. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica 2008;93:431-438
103. González-García I, Rodríguez-Bayona B, Mora-López F, Campos-Caro A, Brieva JA. Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies. Blood 2008;111:741-749.
104. Belnoue E, Pihlgren M, McGaha TL, Tougne C, Rochat AF, Bossen C, Schneider P, Huard B, Lambert PH, Siegrist CA. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells Blood. 2008;111:2755-2764.
105. Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, Hooijkaas H, van Dongen JJ. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997;130:388-393.
106. Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009;9:185-194.
107. Guerrettaz LM, Johnson SA, Cambier JC. Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging. Proc Natl Acad Sci USA 2008;105:11898-11902.
108. Frasca D, Landin AM, Riley RL, Blomberg BB. Mechanisms for decreased function of B cells in aged mice and humans. J Immunol 2008;180:2741-2746.
109. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ III. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006;354:1362-1369.
110. Nieto WG, Almeida J, Romero A, Teodosio C, Lopez A, Henriques AF, Sanchez ML, Jara-Acevedo M, Rasillo A, Gonzalez M, Fernandez-Navarro P, Vega T, Orfao A; Primary Health Care Group of Salamanca for the study of MBL. Increased frequency (12%) of circulating CLL-like B-cell clones in healthy individuals using a high-sensitive multicolor flow cytometry approach. Blood 2009;114:33-37.
111. Han S, Yang K, Ozen Z, Peng W, Marinova E, Kelsoe G, Zheng B. Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice. J Immunol 2003;170:1267-1273.